RF EMerge

A Resource for Innovators

RF EMerge, published by Rothwell Figg, focuses on intellectual property issues intersecting with emerging technologies and life sciences. The blog covers topics such as patent strategies and litigation in biotechnology, pharmaceuticals, and advanced therapeutics including AI-driven drug discovery, targeted protein degradation, mRNA and lipid nanoparticle technologies, and antibody drug conjugates. It also addresses regulatory and compliance developments affecting IP rights, licensing agreements, and freedom to operate analyses. The content reflects Rothwell Figg's expertise in IP law as it applies to cutting-edge innovations in health and technology sectors, providing insights into patent landscapes, strategic partnerships, and legal challenges faced by companies in these fields.

Latest from RF EMerge - Page 2